ALBT Stock Summary and Trading Ideas (Avalon Globocare Corp. | NASDAQ:ALBT)

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Avalon Globocare Corp. trades on the NASDAQ stock market under the symbol ALBT.

As of March 10, 2025, ALBT stock price declined to $5.49 with 128,991 million shares trading.

ALBT has a beta of -0.25, meaning it tends to be less sensitive to market movements. ALBT has a correlation of 0.00 to the broad based SPY ETF.

ALBT has a market cap of $6.01 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that ALBT belongs to (by Net Assets): VXF.

ALBT has underperformed the market in the last year with a return of -8.5%, while SPY returned +10.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ALBT shares. However, ALBT has outperformed the market in the last 3 month and 2 week periods, returning +33.3% and +1.3%, while SPY returned -7.4% and -6.6%, respectively. This indicates ALBT has been having a stronger performance recently.

ALBT support price is $6.27 and resistance is $8.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALBT shares will trade within this expected range on the day.